Effects of medicaid access restrictions on statin utilisation for patients treated by physicians practising in poor and minority neighbourhoods.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2006 AND VI 24 AND IP 3
Results: 17
1
2
Per-patient-per-month drug costs in Medicare Part D protected classes.
- Published in:
- 2006
- By:
- Publication type:
- journal article
3
Impact of Medicaid preferred drug lists on therapeutic adherence.
- Published in:
- 2006
- By:
- Publication type:
- journal article
4
Preferred drug lists and Medicaid prescriptions.
- Published in:
- 2006
- By:
- Publication type:
- journal article
5
Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives?
- Published in:
- 2006
- By:
- Publication type:
- journal article
6
The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: state-level evidence from 1997 to 2003.
- Published in:
- 2006
- By:
- Publication type:
- journal article
7
Medicaid preferred drug lists: cost containment and side effects.
- Published in:
- 2006
- By:
- Publication type:
- journal article
8
Less is more: medicines that require less frequent administration improve adherence, but are they better?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
9
Aromatase inhibitors in breast cancer: a review of cost considerations and cost effectiveness.
- Published in:
- 2006
- By:
- Publication type:
- journal article
10
Trends in outpatient prescription drug use and related costs in the US: 1998-2003.
- Published in:
- 2006
- By:
- Publication type:
- journal article
11
Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective.
- Published in:
- 2006
- By:
- Publication type:
- journal article
12
Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
- Published in:
- 2006
- By:
- Publication type:
- journal article
13
Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias.
- Published in:
- 2006
- By:
- Publication type:
- journal article
14
Quality-of-life valuations of advanced breast cancer by New Zealand women.
- Published in:
- 2006
- By:
- Publication type:
- journal article
15
Eliciting social preference weights for functional assessment of cancer therapy-lung health states.
- Published in:
- 2006
- By:
- Publication type:
- commentary
16
The Authors' Reply.
- Published in:
- PharmacoEconomics, 2006, v. 24, n. 3, p. 294, doi. 10.2165/00019053-200624030-00009
- By:
- Publication type:
- Article
17
Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension.
- Published in:
- 2006
- By:
- Publication type:
- journal article